Resectable, Non-functioning Pituitary Adenoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Resectable, Non-functioning Pituitary Adenoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 2

NCT01203618

Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas

The purpose of this study is to evaluate whether therapy with farletuzumab is effective and safe in the treatment of resectable, non-functioning pituitary adeno…

United States0Started 2011-02

Treatment: Farletuzumab